Four-gene pan-African blood signature predicts progression to tuberculosis

American Journal of Respiratory and Critical Care Medicine

Volumn 197, Issue 9, 2018, Pages 1198-1208

  Suliman, Sara ^a   Thompson, Ethan G ^b   Sutherland, Jayne ^c   Weiner, January ^d   Ota, Martin O C ^c   Shankar, Smitha ^b   Penn Nicholson, Adam ^a   Thiel, Bonnie ^e   Erasmus, Mzwandile ^a   Maertzdorf, Jeroen ^d   Duffy, Fergal J ^b   Hill, Philip C ^f   Jane Hughes, E ^a   Stanley, Kim ^g   Downing, Katrina ^a   Fisher, Michelle L ^a   Valvo, Joe ^b   Parida, Shreemanta K ^d   Van Der Spuy, Gian ^g   Tromp, Gerard ^g   Adetifa, Ifedayo M O ^c   Donkor, Simon ^c   Howe, Rawleigh ^h   Mayanja Kizza, Harriet ⁱ   Henry Boom, W ^e   Dockrell, Hazel M ^j   Ottenhoff, Tom H M ^k   Hatherill, Mark ^a   Aderem, Alan ^b   Hanekom, Willem A ^a   Scriba, Thomas J ^a   Kaufmann, Stefan H E ^d   Zak, Daniel E ^b   Walzl, Gerhard ^g   Black, Gillian F ^g   Kriel, Magdalena ^g   Du Plessis, Nelita ^g   Nene, Nonhlanhla ^g   Roberts, Teri ^g   Kleynhans, Leanie ^g   Gutschmidt, Andrea ^g   Smith, Bronwyn ^g   Loxton, Andre G ^g   Chegou, Novel N ^g   Tabb, David ^g   Klein, Michel R ^k   Haks, Marielle C ^k   Franken, Kees L M C ^k   Geluk, Annemieke ^k   Van Meijgaarden, Krista E ^k   Joosten, Simone A ^k   Joloba, Moses ⁱ   Zalwango, Sarah ⁱ   Nsereko, Mary ⁱ   Okwera, Brenda ⁱ   Kisingo, Hussein ⁱ   Golinski, Robert ^d   Jacobson, Marc ^d   Lalor, Maeve ^j   Smith, Steven ^j   Gorak Stolinska, Patricia ^j   Hur, Yun Gyoung ^j   Lee, Ji Sook ^j   Crampin, Amelia C ^l   French, Neil ^l   Ngwira, Bagrey ^l   Ben Smith, Anne ^l   Watkins, Kate ^l   Ambrose, Lyn ^l   Simukonda, Felanji ^l   Mvula, Hazzie ^l   Chilongo, Femia ^l   Saul, Jacky ^l   Branson, Keith ^l   Mahomed, Hassan ^a   Bilek, Nicole ^a   Xasa, Onke ^a   Veldsman, Ashley ^a   Mulenga, Humphrey ^a   Abel, Brian ^a   Bowmaker, Mark ^a   Kagina, Benjamin ^a   Kwong Chung, William ^a   Sadoff, Jerry ^m   Sizemore, Donata ^m   Ramachandran, S ^m   Barker, Lew ^m   Brennan, Michael ^m   Weichold, Frank ^m   Muller, Stefanie ^m   Geiter, Larry ^m   Kassa, Desta ⁿ   Abebe, Almaz ⁿ   Mesele, Tsehayenesh ⁿ   Tegbaru, Belete ⁿ   Van Baarle, Debbie ^o   Miedema, Frank ^o   Mihret, Adane ^h   Aseffa, Abraham ^h   Bekele, Yonas ^h   Iwnetu, Rachel ^h   Tafesse, Mesfin ^h   Yamuah, Lawrence ^h   Adegbola, Richard ^c   Corrah, Tumani ^c   Antonio, Martin ^c   Togun, Toyin ^c   Andersen, Peter ^p   Rosenkrands, Ida ^p   Doherty, Mark ^p   Weldingh, Karin ^p   Schoolnik, Gary ^q   Dolganov, Gregory ^q   Van, Tran ^q   Kafaar, Fazlin ^a   Workman, Leslie ^a   Cloete, Yolundi ^a   Abrahams, Deborah ^a   Moyo, Sizulu ^a   Gelderbloem, Sebastian ^a   Tameris, Michele ^a   Geldenhuys, Hennie ^a   Hussey, Gregory ^a   Ehrlich, Rodney ^r   Verver, Suzanne ^s,t   more..

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

^c Medical Research Council Unit   (Gambia)

^d MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

^e CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF OTAGO   (New Zealand)

^g UNIVERSITY OF STELLENBOSCH   (South Africa)

^h ARMAUER HANSEN RESEARCH INSTITUTE   (Ethiopia)

ⁱ MAKERERE UNIVERSITY   (Uganda)

^j LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^k LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^l KARONGA PREVENTION STUDY   (Malawi)

^m AERAS   (United States)

ⁿ ETHIOPIAN PUBLIC HEALTH INSTITUTE   (Ethiopia)

^o UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^p STATENS SERUM INSTITUT   (Denmark)

^q STANFORD UNIVERSITY   (United States)

^r UNIVERSITY OF CAPE TOWN   (South Africa)

^s KNCV TUBERCULOSIS FOUNDATION   (Netherlands)

^t AMSTERDAM INSTITUTE FOR GLOBAL HEALTH AND DEVELOPMENT   (Netherlands)

more..

Author keywords

Biomarkers; Gene expression; Tuberculosis

Indexed keywords

COMPLEMENT COMPONENT C1Q; T LYMPHOCYTE RECEPTOR ALPHA CHAIN;

ADOLESCENT; ADULT; AFRICAN; ALGORITHM; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE EXACERBATION; ETHIOPIA; FEMALE; FOLLOW UP; GAMBIA; GAMBIAN; GENE EXPRESSION; GENETIC VARIABILITY; HOUSEHOLD; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; POPULATION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; SOUTH AFRICA; SOUTH AFRICAN; T LYMPHOCYTE RECEPTOR GENE; UGANDA;

EID: 85046554525     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201711-2340OC     Document Type: Article

References (43)

1. Riley F. Tuberculosis in hospital nurses; five years figures. Mon Bull Minist Health Public Health Lab Serv 1959;18:38-45.
2. Yates TA, Khan PY, Knight GM, Taylor JG, McHugh TD, Lipman M, et al. The transmission of Mycobacterium tuberculosis in high burden settings. Lancet Infect Dis 2016;16:227-238.
3. World Health Organization (WHO). Global tuberculosis report 2017 [accessed 2018 Jan 26]. Available from: http://www.who.int/tb/publications/global-report/gtbr2017-main-text.pdf?u a=1.
4. Rieder H. Annual risk of infection with Mycobacterium tuberculosis. Eur Respir J 2005;25:181-185.
5. O'Garra A, Redford PS, McNab FW, Bloom CI, Wilkinson RJ, BerryMP. The immune response in tuberculosis. Annu Rev Immunol 2013;31:475-527.
6. Andrews JR, Noubary F, Walensky RP, Cerda R, Losina E, Horsburgh CR. Risk of progression to active tuberculosis following reinfectionwith Mycobacterium tuberculosis. Clin Infect Dis 2012;54:784-791.
7. Cobelens F, Kik S, Esmail H, Cirillo DM, Lienhardt C, Matteelli A. From latent to patent: rethinking prediction of tuberculosis. Lancet Respir Med 2017;5:243-244.
8. World Health Organization (WHO). Development of a Target Product Profile (TPP) and a framework for evaluation for a test for predicting progression from tuberculosis infection to active disease [accessed 2018 Jan 26]. Available from: http://apps.who.int/iris/bitstream/10665/259176/1/WHO-HTM-TB-2017.18-eng.pdf
9. Sester M, van Crevel R, van Leth F, Lange C. Numbers needed to treat to prevent tuberculosis. Eur Respir J 2015;46:1836-1838.
10. Blaser N, Zahnd C, Hermans S, Salazar-Vizcaya L, Estill J, Morrow C, et al. Tuberculosis in Cape Town: an age-structured transmission model. Epidemics 2016;14:54-61.
11. Wood R, Lawn SD, Caldwell J, Kaplan R, Middelkoop K, Bekker LG. Burden of new and recurrent tuberculosis in a major South African city stratified by age and HIV-status. PLoS One 2011;6: e25098.
12. Kasaie P, Andrews JR, Kelton WD, Dowdy DW. Timing of tuberculosis transmission and the impact of household contact tracing: an agentbased simulation model. Am J Respir Crit Care Med 2014;189: 845-852.
13. Fox GJ, Barry SE, Britton WJ, Marks GB. Contact investigation for tuberculosis: a systematic review and meta-analysis. Eur Respir J 2013;41:140-156.
14. Abu-Raddad LJ, Sabatelli L, Achterberg JT, Sugimoto JD, Longini IM Jr, Dye C, et al. Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics. Proc Natl Acad Sci USA 2009;106: 13980-13985.
15. Dye C, Glaziou P, Floyd K, Raviglione M. Prospects for tuberculosis elimination. Annu Rev Public Health 2013;34:271-286.
16. Coussens AK, Wilkinson RJ, Nikolayevskyy V, Elkington PT, Hanifa Y, Islam K, et al. Ethnic variation in inflammatory profile in tuberculosis. PLoS Pathog 2013;9:e1003468.
17. Comas I, Coscolla M, Luo T, Borrell S, Holt KE, Kato-Maeda M, et al. Out-of-Africa migration and Neolithic coexpansion of Mycobacterium tuberculosis with modern humans. Nat Genet 2013;45:1176-1182.
18. Denkinger CM, Kik SV, Cirillo DM, Casenghi M, Shinnick T, Weyer K, et al. Defining the needs for next generation assays for tuberculosis. J Infect Dis 2015;211(Suppl 2):S29-S38.
19. Berry MP, Graham CM, McNab FW, Xu Z, Bloch SA, Oni T, et al. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 2010;466:973-977.
20. Maertzdorf J, Repsilber D, Parida SK, Stanley K, Roberts T, Black G, et al. Human gene expression profiles of susceptibility and resistance in tuberculosis. Genes Immun 2011;12:15-22.
21. Joosten SA, Fletcher HA, Ottenhoff TH. A helicopter perspective on TB biomarkers: pathway and process based analysis of gene expression data provides new insight into TB pathogenesis. PLoS One 2013;8: e73230.
22. Cliff JM, Lee JS, Constantinou N, Cho JE, Clark TG, Ronacher K, et al. Distinct phases of blood gene expression pattern through tuberculosis treatment reflect modulation of the humoral immune response. J Infect Dis 2013;207:18-29.
23. Cliff JM, Kaufmann SH, McShane H, van Helden P, O'Garra A. The human immune response to tuberculosis and its treatment: a view from the blood. Immunol Rev 2015;264:88-102.
24. Ottenhoff TH, Dass RH, Yang N, Zhang MM, Wong HE, Sahiratmadja E, et al. Genome-wide expression profiling identifies type 1 interferon response pathways in active tuberculosis. PLoS One 2012;7:e45839.
25. Zak DE, Penn-Nicholson A, Scriba TJ, Thompson E, Suliman S, Amon LM, et al.; ACS and GC6-74 cohort study groups. A blood RNA signature for tuberculosis disease risk: a prospective cohort study. Lancet 2016;387:2312-2322.
26. Churchyard G, Gupta A, Swindells S, Hesseling A, Opollo V, Suryavanshi N, et al.; A5300/I2003 Study Team. Accessing MDR-TB exposed households: the PHOENiX MDR-TB feasibility study. Presented at the 48th Union Conference on Lung Health. October 14, 2017, Guadalajara, Mexico.
27. Kaufmann SHE. Predictive biosignatures to improve tuberculosis vaccine development. Presented at the Fifth Global Forum on TB Vaccines. February 22, 2018, New Delhi, India.
28. Mahomed H, Hawkridge T, Verver S, Geiter L, Hatherill M, Abrahams DA, et al.; SATVI Adolescent Study Team. Predictive factors for latent tuberculosis infection among adolescents in a high-burden area in South Africa. Int J Tuberc Lung Dis 2011;15:331-336.
29. Thompson EG, Du Y, Malherbe ST, Shankar S, Braun J, Valvo J, et al.; Catalysis TB-Biomarker Consortium. Host blood RNA signatures predict the outcome of tuberculosis treatment. Tuberculosis (Edinb) 2017;107:48-58.
30. Maertzdorf J, McEwen G, Weiner J III, Tian S, Lader E, Schriek U, et al. Concise gene signature for point-of-care classification of tuberculosis. EMBO Mol Med 2016;8:86-95.
31. Sweeney TE, Braviak L, Tato CM, Khatri P. Genome-wide expression for diagnosis of pulmonary tuberculosis: a multicohort analysis. Lancet Respir Med 2016;4:213-224.
32. Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, et al. pROC: an open-source package for R and S1 to analyze and compare ROC curves. BMC Bioinformatics 2011;12:77.
33. de Jong BC, Hill PC, Aiken A, Awine T, Antonio M, Adetifa IM, et al. Progression to active tuberculosis, but not transmission, varies by Mycobacterium tuberculosis lineage in The Gambia. J Infect Dis 2008;198:1037-1043.
34. Adetifa IM, Kendall L, Bashorun A, Linda C, Omoleke S, Jeffries D, et al. A tuberculosis nationwide prevalence survey in Gambia, 2012. Bull World Health Organ 2016;94:433-441.
35. Petruccioli E, Scriba TJ, Petrone L, Hatherill M, Cirillo DM, Joosten SA, et al. Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosis. Eur Respir J 2016;48: 1751-1763.
36. Fiore-Gartland A, Carpp LN, Kogieleum N, Thompson E, Zak DE, et al. Considerations for biomarker-targeted intervention strategies for tuberculosis disease prevention. Tuberculosis (Edinb) 2018;109: 61-68.
37. Penn-Nicholson A, Scriba TJ, Hatherill M, White RG, Sumner T. A novel blood test for tuberculosis prevention and treatment. S Afr Med J 2016;107:4-5.
38. Villani AC, Satija R, Reynolds G, Sarkizova S, Shekhar K, Fletcher J, et al. Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors. Science 2017;356: eaah4573.
39. Fuchs Y, Brown S, Gorenc T, Rodriguez J, Fuchs E, Steller H. Sept4/ARTS regulates stem cell apoptosis and skin regeneration. Science 2013;341:286-289.
40. Scriba TJ, Penn-Nicholson A, Shankar S, Hraha T, Thompson EG, Sterling D, et al.; other members of the ACS cohort study team. Sequential inflammatory processes define human progression from M. tuberculosis infection to tuberculosis disease. PLoS Pathog 2017; 13:e1006687.
41. Gideon HP, Skinner JA, Baldwin N, Flynn JL, Lin PL. Early whole blood transcriptional signatures are associated with severity of lung inflammation in cynomolgus macaques with Mycobacterium tuberculosis infection. J Immunol 2016;197:4817-4828.
42. Wallgren A. The time-table of tuberculosis. Tubercle 1948;29: 245-251.
43. Poulsen A. Some clinical features of tuberculosis. 1. Incubation period. Acta Tuberc Pneumol Scand 1950;24:311-346.